Hudson Bay Capital Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-3,000
| Closed | -$3.58M | – | 413 |
|
|
2019
Q2 | $3.58M | Buy |
3,000
+500
| +20% | +$596K | 0.08% | 194 |
|
|
2019
Q1 | $3.12M | Sell |
2,500
-1,000
| -29% | -$1.25M | 0.04% | 221 |
|
|
2018
Q4 | $3.32M | Buy |
3,500
+1,800
| +106% | +$1.7M | 0.04% | 214 |
|
|
2018
Q3 | $2.45M | Buy |
1,700
+500
| +42% | +$720K | 0.03% | 247 |
|
|
2018
Q2 | $1.94M | Buy |
1,200
+200
| +20% | +$323K | 0.03% | 286 |
|
|
2018
Q1 | $1.62M | Sell |
1,000
-400
| -29% | -$649K | 0.03% | 271 |
|
|
2017
Q4 | $2.35M | Buy |
1,400
+150
| +12% | +$252K | 0.05% | 202 |
|
|
2017
Q3 | $1.75M | Buy |
1,250
+448
| +56% | +$627K | 0.04% | 200 |
|
|
2017
Q2 | $894K | Buy |
+802
| New | +$894K | 0.02% | 267 |
|